Image pharmaphorum Editor R&D Research & Development 2023 So, what does 2023 have in store for pharma R&D? Digital Tackling ongoing staffing burnout rates through AI-enabled p... The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows. Market Access Breaking through the forecasting fog - 3 trends that will im... As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future. Sales & Marketing Automating - and optimising - HCP engagement to maximise com... Life sciences marketing has rapidly evolved to mirror that of consumer retail. Load more results
Digital Tackling ongoing staffing burnout rates through AI-enabled p... The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows.
Market Access Breaking through the forecasting fog - 3 trends that will im... As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future.
Sales & Marketing Automating - and optimising - HCP engagement to maximise com... Life sciences marketing has rapidly evolved to mirror that of consumer retail.
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
